Renascience Inc.

4889

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-14FY2027 Q1

Revenue

YoY -

Operating Income

-82,093,000JPY

YoY +19.7%

Net Income

-3.2100M JPY

YoY -598.4%

EPS

-6.0JPY

YoY -13.1%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

1.9億円

56.3百万円

-81.4百万円

-2.2億円

-3.6億円

Rev: 1.4億円Op: -2.1億円NI: -2.5億円

Rev: 1億円Op: -3.3億円NI: -3.4億円

Rev: 1.9億円Op: -2.5億円NI: -2.6億円

Rev: 1.3億円Op: -1.8億円NI: 1.1億円

Rev: 68百万円Op: -3.6億円NI: -3億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income-

Revenue Progress-

Revenue Forecast-

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan